Celltrion Pharm

068760.KQ

44.43 USD

-1.14

-2.50%

Overview

Last close

44.43 usd

Market cap

1.93B usd

52 week high

69.97 usd

52 week low

30.18 usd

Target price

93.93 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

10.5266

Price/Book Value

6.9796

Enterprise Value

2.04B usd

EV/Revenue

5.8327

EV/EBITDA

40.9186

Key financials

Revenue TTM

189.74M usd

Gross Profit TTM

55.83M usd

EBITDA TTM

29.56M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

538.06M usd

Net debt

89.30M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.